UiPath's Agentic AI Targets RCM's Three Hardest Problems
UiPath launched an agentic AI suite for medical records review, denial management, and prior authorization. Medlitix reported a 90% reduction in summary review time — from 70 minutes to six. Here's what it means for RCM teams.
The announcement is notable less for the technology itself — AI-assisted summarization and denial workflows have been in vendor roadmaps for two years — and more for the benchmark data attached to it.
That figure, if reproducible at scale, changes the calculus for clinical documentation review teams. Most prior auth denials involving medical necessity sit in a review queue for days before a human touches it. Cutting that step from 70 to 6 minutes doesn't just reduce cost — it compresses the cycle time between submission and appeal.
"Since implementing the UiPath MRS solution, we've reduced the average summary review time from 70 minutes to six, a 90 per cent improvement. Our clinicians are spending more time on direct patient care and less time digging through documentation."
— Benjamin Smith, VP of Technology, Medlitix
What the Three Products Actually Do
Medical Records Summarization: Structured output with citations traceable back to source documents. The design choice here — traceability — is what distinguishes it from a generic summarization tool. In a denial appeal, you need to cite the specific clinical record that supports medical necessity. A summary that can't do that isn't usable in the revenue cycle context.
Denial Prevention and Resolution: Root cause identification, coordinated appeals across departments, compliance standardization. The harder problem in denial management has never been writing the appeal — it's identifying the root cause early enough to prevent the denial before it lands. UiPath's framing suggests the agent identifies corrective steps before the claim hits the payer's review queue.
Prior Authorization Automation: Eligibility checks, benefits validation, clinical rule mapping, and status tracking in a single workflow. The bottleneck in prior auth isn't the approval itself — it's the lookup time to verify what the payer requires before submission. Automating that step is where the ROI compounds.
The Genzeon Partnership and Regulatory Context
UiPath has partnered with Genzeon, an AI-driven healthcare technology firm selected by CMS for the Wasteful and Inappropriate Service Reduction model. The partnership embeds payer-side compliance expertise into the agent workflows — UiPath handles the automation layer, Genzeon provides the clinical and regulatory guardrails that keep agentic decisions defensible in a CMS audit context.
That structure matters. Agentic AI in a claims environment isn't just a workflow tool — it's making decisions that affect reimbursement and compliance. Pairing automation capability with regulatory domain knowledge is the right architecture for this use case.
What This Means for RCM Teams
The vendors are arriving. Large enterprise RCM platforms — UiPath, Epic, Oracle Health — are all landing agentic AI into their roadmaps in 2026. For RCM directors, this creates two near-term decisions:
Vendor Evaluation
Which automation layer sits on top of your existing EHR and billing system? UiPath is betting on platform-agnostic connectivity across fragmented systems — the correct bet for organizations not on a single EHR vendor stack. Pilot before committing; Medlitix's 90% figure needs validation against your own payer mix.
The Prior Auth Gap That Automation Doesn't Solve
Automating eligibility and clinical rule mapping is only as fast as the payer policy data feeding it. Payers update requirements 4–5 times per year with no advance notice. Organizations that have already solved the upstream payer knowledge problem will get the most from what tools like UiPath are building.
Get Exact Payer Policy Language with Axlow
Agentic AI workflows need accurate payer policy data upstream. Axlow returns the exact prior auth criteria, coverage guidelines, and documentation requirements for any payer in 20 seconds.